Community Research and Development Information Service - CORDIS

Novel Personalized Cellular Therapy Approach for Immune Diseases

From 2018-07-01 to 2021-06-30, ongoing project

Project details

Total cost:

EUR 3 850 000

EU contribution:

EUR 2 695 000

Coordinated in:

Sweden

Call for proposal:

H2020-SMEInst-2018-2020-2See other projects for this call

Funding scheme:

SME-2 - SME instrument phase 2

Objective

Coordinator

TLA TARGETED IMMUNOTHERAPIES AB
Sweden

EU contribution: EUR 2 695 000


EKONOMILANKEN AB BOX 726
191 27 SOLLENTUNA
Sweden
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top